Literature DB >> 19003182

Evaluation and optimization of hepatocyte culture media factors by design of experiments (DoE) methodology.

Jia Dong1, Carl-Fredrik Mandenius, Marc Lübberstedt, Thomas Urbaniak, Andreas K N Nüssler, Daniel Knobeloch, Jörg C Gerlach, Katrin Zeilinger.   

Abstract

Optimization of cell culture media based on statistical experimental design methodology is a widely used approach for improving cultivation conditions. We applied this methodology to refine the composition of an established culture medium for growth of a human hepatoma cell line, C3A. A selection of growth factors and nutrient supplements were systematically screened according to standard design of experiments (DoE) procedures. The results of the screening indicated that the medium additives hepatocyte growth factor, oncostatin M, and fibroblast growth factor 4 significantly influenced the metabolic activities of the C3A cell line. Surface response methodology revealed that the optimum levels for these factors were 30 ng/ml for hepatocyte growth factor and 35 ng/ml for oncostatin M. Additional experiments on primary human hepatocyte cultures showed high variance in metabolic activities between cells from different individuals, making determination of optimal levels of factors more difficult. Still, it was possible to conclude that hepatocyte growth factor, epidermal growth factor, and oncostatin M had decisive effects on the metabolic functions of primary human hepatocytes.

Entities:  

Year:  2008        PMID: 19003182      PMCID: PMC2570004          DOI: 10.1007/s10616-008-9168-6

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  13 in total

1.  Bioprocess optimization using design-of-experiments methodology.

Authors:  Carl-Fredrik Mandenius; Anders Brundin
Journal:  Biotechnol Prog       Date:  2008 Nov-Dec

2.  Evaluation of primary human liver cells in bioreactor cultures for extracorporeal liver support on the basis of urea production.

Authors:  Gesine Pless; Ingo Steffen; Katrin Zeilinger; Igor M Sauer; Ekaterina Katenz; Daniel C Kehr; Stephan Roth; Tim Mieder; Ruth Schwartlander; Christian Müller; Brigitte Wegner; Mariah S Hout; Jörg C Gerlach
Journal:  Artif Organs       Date:  2006-09       Impact factor: 3.094

3.  Identification and characterization of cellular receptors for the growth regulator, oncostatin M.

Authors:  P S Linsley; M Bolton-Hanson; D Horn; N Malik; J C Kallestad; V Ochs; J M Zarling; M Shoyab
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

4.  Quantitative screening of embryonic stem cell differentiation: endoderm formation as a model.

Authors:  Karen H Chang; Peter W Zandstra
Journal:  Biotechnol Bioeng       Date:  2004-11-05       Impact factor: 4.530

5.  Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study.

Authors:  Jörg C Gerlach; Kerim Mutig; Igor M Sauer; Petra Schrade; Ekaterina Efimova; Tim Mieder; Götz Naumann; Andreas Grunwald; Gesine Pless; Antoni Mas; Sebastian Bachmann; Peter Neuhaus; Katrin Zeilinger
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

6.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.

Authors:  J M Zarling; M Shoyab; H Marquardt; M B Hanson; M N Lioubin; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture.

Authors:  M J Gómez-Lechón; J Castelli; I Guillén; E O'Connor; T Nakamura; R Fabra; R Trullenque
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

8.  Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes.

Authors:  A J Strain; T Ismail; H Tsubouchi; N Arakaki; T Hishida; N Kitamura; Y Daikuhara; P McMaster
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

9.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium.

Authors:  G D Block; J Locker; W C Bowen; B E Petersen; S Katyal; S C Strom; T Riley; T A Howard; G K Michalopoulos
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

10.  Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system.

Authors:  L Wang; J Sun; L Li; D Mears; M Horvat; A G Sheil
Journal:  Cell Transplant       Date:  1998 Sep-Oct       Impact factor: 4.139

View more
  9 in total

1.  Optimization of a serum-free culture medium for mouse embryonic stem cells using design of experiments (DoE) methodology.

Authors:  Fanny Knöspel; Rudolf K Schindler; Marc Lübberstedt; Stephanie Petzolt; Jörg C Gerlach; Katrin Zeilinger
Journal:  Cytotechnology       Date:  2010-09-22       Impact factor: 2.058

2.  Regulatory subunit I-controlled protein kinase A activity is required for apical bile canalicular lumen development in hepatocytes.

Authors:  Kacper A Wojtal; Mandy Diskar; Friedrich W Herberg; Dick Hoekstra; Sven C D van Ijzendoorn
Journal:  J Biol Chem       Date:  2009-05-22       Impact factor: 5.157

3.  Facile development of medium optimization for antibody production: implementation in spinner flask and hollow fiber reactor.

Authors:  Chi-Hsien Liu; Yi-Xin Liu; Wei-Chi Wu
Journal:  Cytotechnology       Date:  2018-10-03       Impact factor: 2.058

4.  Advantages of AlaGln as an additive to cell culture medium: use with anti-CD20 chimeric antibody-producing POTELLIGENT™ CHO cell lines.

Authors:  Yasufumi Imamoto; Hisaya Tanaka; Ken Takahashi; Yoshinobu Konno; Toshiyuki Suzawa
Journal:  Cytotechnology       Date:  2012-06-14       Impact factor: 2.058

5.  Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods.

Authors:  Andrea Gray; Timothy Maguire; Rene Schloss; Martin L Yarmush
Journal:  Biotechnol Prog       Date:  2015-05-28

6.  Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody.

Authors:  Huifeng Zhang; Haibin Wang; Mei Liu; Tao Zhang; Ji Zhang; Xiangjing Wang; Wensheng Xiang
Journal:  Cytotechnology       Date:  2012-08-21       Impact factor: 2.058

7.  High-throughput nano-biofilm microarray for antifungal drug discovery.

Authors:  Anand Srinivasan; Kai P Leung; Jose L Lopez-Ribot; Anand K Ramasubramanian
Journal:  MBio       Date:  2013-06-25       Impact factor: 7.867

8.  Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro.

Authors:  Leonard J Nelson; Philipp Treskes; A Forbes Howie; Simon W Walker; Peter C Hayes; John N Plevris
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 9.  Clever Experimental Designs: Shortcuts for Better iPSC Differentiation.

Authors:  Ryota Yasui; Keisuke Sekine; Hideki Taniguchi
Journal:  Cells       Date:  2021-12-15       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.